Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

The effects of nebulized albuterol on esophageal function in asthmatic patients.

Lacy BE, Mathis C, DesBiens J, Liu MC.

Dig Dis Sci. 2008 Oct;53(10):2627-33. doi: 10.1007/s10620-007-0188-4. Epub 2008 Feb 13.

PMID:
18270832
2.

Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity.

Dal Negro RW, Turco P, Micheletto C, Tognella S, Bonadiman L, Guerriero M, Sandri M.

Respir Med. 2007 Aug;101(8):1814-20. Epub 2007 Apr 6.

3.

Analysis of exacerbation rates in asthma and chronic obstructive pulmonary disease: example from the TRISTAN study.

Keene ON, Jones MR, Lane PW, Anderson J.

Pharm Stat. 2007 Apr-Jun;6(2):89-97.

PMID:
17230434
4.

Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.

American Lung Association Asthma Clinical Research Centers.

Am J Respir Crit Care Med. 2007 Feb 1;175(3):235-42. Epub 2006 Sep 22.

PMID:
16998094
5.

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.

Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB.

Am J Respir Crit Care Med. 2006 May 15;173(10):1091-7. Epub 2005 Dec 15.

PMID:
16357331
6.

Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.

Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee.

Respir Med. 2006 Apr;100(4):616-21. Epub 2005 Oct 13.

7.

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.

Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK; Lansoprazole Asthma Study Group.

Chest. 2005 Sep;128(3):1128-35.

PMID:
16162697
8.

Standardisation of spirometry.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Aug;26(2):319-38. No abstract available.

9.

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

Donnellan C, Sharma N, Preston C, Moayyedi P.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003245. Review. Update in: Cochrane Database Syst Rev. 2010;(2):CD003245.

PMID:
15846653
10.

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.

DeVault KR, Castell DO; American College of Gastroenterology.

Am J Gastroenterol. 2005 Jan;100(1):190-200.

PMID:
15654800
11.

The prevalence of gastroesophageal reflux disease in adult asthmatics.

Kiljander TO, Laitinen JO.

Chest. 2004 Nov;126(5):1490-4.

PMID:
15539717
12.

Reflex mechanisms in gastroesophageal reflux disease and asthma.

Canning BJ, Mazzone SB.

Am J Med. 2003 Aug 18;115 Suppl 3A:45S-48S. Review.

PMID:
12928074
13.

Gastro-oesophageal reflux treatment for asthma in adults and children.

Gibson PG, Henry RL, Coughlan JL.

Cochrane Database Syst Rev. 2003;(2):CD001496. Review.

PMID:
12804410
14.

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.

Ours TM, Fackler WK, Richter JE, Vaezi MF.

Am J Gastroenterol. 2003 Mar;98(3):545-50.

PMID:
12650785
15.

Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma.

Zerbib F, Guisset O, Lamouliatte H, Quinton A, Galmiche JP, Tunon-De-Lara JM.

Am J Respir Crit Care Med. 2002 Nov 1;166(9):1206-11.

PMID:
12403689
17.
18.

Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthma.

Wu DN, Tanifuji Y, Kobayashi H, Yamauchi K, Kato C, Suzuki K, Inoue H.

Chest. 2000 Dec;118(6):1553-6.

PMID:
11115439
19.

The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms.

Harding SM, Guzzo MR, Richter JE.

Am J Respir Crit Care Med. 2000 Jul;162(1):34-9.

PMID:
10903216
20.

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ.

Am J Respir Crit Care Med. 2000 Jan;161(1):309-29. No abstract available.

PMID:
10619836

Supplemental Content

Support Center